(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain-the Swoop® system-today announced ...
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI ...
Hyperfine Swoop® System Introduced as India’s First Portable MRI for Bedside Brain Imaging at the Country’s Leading Medical Institution The All India Institute of Medical Sciences, New Delhi, in ...
Intersocietal Accreditation Commission (IAC)’s release of new standards accepting ultra-low-field MRI technology enables accredited facilities to qualify for reimbursement from the US Centers for ...
The SAFE MRI ECMO study evaluated the use of ultra-low-field portable MR imaging on ICU patients undergoing extracorporeal membrane oxygenation (ECMO) with an elevated risk of acute brain injury (ABI) ...
Hyperfine received FDA clearance for its next-generation Swoop Portable MR Imaging system. HYPR's new Swoop system uses OptiVu AI to enhance image resolution, speed, and diagnostic utility. Hyperfine ...
GUILFORD, Conn., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop ® system, the world's first FDA-cleared portable MRI ...
The Swoop system tackles a critical challenge in health care, limited access to affordable and prompt brain imaging. More than three billion people globally are affected by brain diseases, including ...
UniHA approves framework agreement covering over 1,500 French public hospitals, facilitating the purchase of Swoop® AI-powered portable MRI systems over three years GUILFORD, Conn., October 13, 2025-- ...
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance ...
New dementia study actively enrolling and new data to be presented at the 2025 Alzheimer's Association International Conference. GUILFORD, Conn., July 24, 2025--(BUSINESS WIRE)--Hyperfine, Inc.